ArticleBioengineered2021

miR-148a-3p suppresses the progression of acute myeloid leukemia via targeting cyclin-dependent kinase 6 (CDK6).

Hong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.